Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

ID Biomedical's flu vaccine granted fast track status

ID Biomedical Corporation announced today it has been advised by the United States Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) that the Company's Influenza Virus Vaccine (Fluviral) has been granted a Fast Track designation.

13 Jul 2005

Cordis release new stent featuring the latest advancement in balloon-expandable stent technology

Cordis Endovascular, today announced the U.S. launch of the PALMAZ(R) BLUE(TM) Transhepatic Biliary Cobalt Chromium Stent, the latest advancement in balloon-expandable stent technology. Featuring L605, a cobalt alloy enhanced with tungsten, the PALMAZ(R) BLUE(TM) Stent is stronger than stainless steel stents and uses less metal.

1 Jul 2005

GlaxoSmithKline announces availability of Paxil CR to U.S. market

GlaxoSmithKline announced today the availability of Paxil CR (paroxetine hydrochloride controlled release) tablets in pharmacies across the United States. Other markets will follow shortly thereafter.

27 Jun 2005

Cordis patents infringed by Boston Scientific Stents

Cordis Corporation today announced that a U.S. District Court jury in Wilmington, Delaware found that Boston Scientific's Taxus drug-eluting stent and its Liberte and Express bare metal stents infringe Cordis' pioneering Palmaz patent for balloon expandable stents

21 Jun 2005

Older drinkers not younger, most likely to succumb to alcohol-related death

An extraordinary amount of media attention focuses on alcohol consumption and its impact on public order and health. But as Professor Dick Hobbs shows in ESRC's new report Seven Deadly Sins, while 'binge drinking' youths dominate the headlines, it is older drinkers that are most likely to succumb to alcohol-related death.

19 Jun 2005

Vical receives $12 Million HIV vaccine order

Vical Incorporated announced today the receipt of approximately $12.1 million in production orders for multiple clinical lots of DNA vaccines against HIV for the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, under a subcontract managed by SAIC-Frederick, Inc.

16 Jun 2005

Strategic analysis of the European regional anaesthesia kits market

Growing awareness of regional anaesthesia’s myriad benefits has boosted the number of such procedures being performed across Europe. This trend is, in turn, set to trigger increased uptake of regional anaesthesia kits.

14 Jun 2005

Solving the hospital crisis with mathematical, statistical and software tools

Melbourne researchers are hoping to ease the strain of bed shortages and limited resources in Australian hospitals in a project to develop mathematical, statistical and software tools that will enable hospital managers to see where queues or available resources exist within the hospital system.

6 Jun 2005

Ranbaxy makes further three filings of its Anti-Retroviral (ARVs) formulations

Ranbaxy Laboratories Limited has announced that the Company has made further three filings of its Anti-Retroviral (ARVs) formulations, to the World Health Organization (WHO) for its approval under the latter's pre-qualification project for HIV/AIDS drugs.

30 May 2005

Targeted Genetics announces new patent for Hyperlipidemia

Targeted Genetics Corporation announced today issuance of U.S. patent #6,887,463, entitled, "Methods and Compositions for Gene Therapy for the Treatment of Defects in Lipoprotein Metabolism."

11 May 2005

Fragile US vaccine system needs improvement

A comprehensive system of vaccine development in the U.S. resulted in a reduction of 87 to more than 99 percent in illness from ten vaccine-preventable diseases during the twentieth century. These dramatic successes should not be taken for granted, however, as the vaccine system now faces numerous challenges in manufacturing and development, according to a review article in the May/June issue of Health Affairs.

10 May 2005

CSMA examines medical devices - tests for the characterisation and analysis of catheter tubing

CSMA has recently developed a unique range of tests for the characterisation and analysis of catheter tubing. CSMA is the only company in Europe to offer a standard suite of tests related specifically to catheter tubing manufacturers.

5 May 2005

New Zealand Ministry of Health to consider Vaxigrip vaccine trial results

Pharmac and the New Zealand Ministry of Health are aware that Sanofi-Pasteur has been running a clinical trial to demonstrate the efficacy of their influenza vaccine, Vaxigrip.

4 May 2005

GlaxoSmithKline to acquire Corixa Corporation

GlaxoSmithKline has announced the execution of a definitive agreement pursuant to which GSK will acquire Corixa Corporation, a developer of innovative products that regulate immunity, based in Seattle, WA (USA).

2 May 2005

Trial to evaluate modern stent technologies over balloon angioplasty for peripheral arterial disease

The first patient undergoes treatment today in a new prospective randomised trial, called the SUPER Study, to compare stenting with balloon angioplasty in patients with superficial femoral artery (SFA) occlusions caused by peripheral artery disease (PAD).

28 Apr 2005

SkyePharma and GlaxoSmithKline reach agreement on payment of royalties for Paxil CR

SkyePharma has announced that it has entered into an amendment agreement with GlaxoSmithKline (GSK) in respect of Paxil CR. Under the terms of the amendment agreement, GSK will make a one-time payment of approximately $10 million.

28 Apr 2005

Patients' lives at risk from substandard drugs say heart specialists

Global action is needed to counter the dangers of substandard life-saving drugs that are putting patients' lives and health at risk, according to heart specialists writing in the new (19 April) issue of Europe's leading cardiology journal, the European Heart Journal.

27 Apr 2005

Pfizer recalls epilepsy medicine

Pfizer has voluntarily recalled one lot (40,000 bottles) of 100 mg capsules of its epilepsy medication, Neurontin, after a manufacturing mechanical failure resulted in some bottles containing empty or partially filled capsules.

23 Apr 2005

Halozyme Therapeutics receives FDA clearance for Cumulase

Halozyme Therapeutics has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Cumulase for the treatment of oocytes to facilitate certain in vitro fertilization (IVF) procedures. The active pharmaceutical ingredient in Cumulase is the first and only recombinant human hyaluronidase approved in the United States for cumulus removal in the IVF process.

20 Apr 2005

New chemical reaction that could greatly accelerate pharmaceutical production

University of Toronto researchers have a developed a new chemical reaction that could greatly accelerate pharmaceutical production, while also cutting costs and toxic by-products.

19 Apr 2005